Motif 1205 (n=44)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
C9JAW5 | None | S8 | ochoa | HIG1 domain-containing protein | None |
O43299 | AP5Z1 | S8 | ochoa | AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5) | As part of AP-5, a probable fifth adaptor protein complex it may be involved in endosomal transport. According to PubMed:20613862 it is a putative helicase required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20613862, ECO:0000269|PubMed:22022230}. |
O43929 | ORC4 | S8 | ochoa | Origin recognition complex subunit 4 | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3. {ECO:0000269|PubMed:22427655}. |
O60716 | CTNND1 | S8 | ochoa | Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)) | Key regulator of cell-cell adhesion that associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability (PubMed:14610055, PubMed:20371349). Promotes localization and retention of DSG3 at cell-cell junctions, via its interaction with DSG3 (PubMed:18343367). Beside cell-cell adhesion, regulates gene transcription through several transcription factors including ZBTB33/Kaiso2 and GLIS2, and the activity of Rho family GTPases and downstream cytoskeletal dynamics (PubMed:10207085, PubMed:20371349). Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors (PubMed:17344476). {ECO:0000269|PubMed:10207085, ECO:0000269|PubMed:14610055, ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:18343367, ECO:0000269|PubMed:20371349}. |
O75563 | SKAP2 | S8 | ochoa | Src kinase-associated phosphoprotein 2 (Pyk2/RAFTK-associated protein) (Retinoic acid-induced protein 70) (SKAP55 homolog) (SKAP-55HOM) (SKAP-HOM) (Src family-associated phosphoprotein 2) (Src kinase-associated phosphoprotein 55-related protein) (Src-associated adapter protein with PH and SH3 domains) | May be involved in B-cell and macrophage adhesion processes. In B-cells, may act by coupling the B-cell receptor (BCR) to integrin activation. May play a role in src signaling pathway. {ECO:0000269|PubMed:12893833, ECO:0000269|PubMed:9837776}. |
O75821 | EIF3G | S8 | ochoa | Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44) | RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). This subunit can bind 18S rRNA. {ECO:0000255|HAMAP-Rule:MF_03006, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. |
O75909 | CCNK | S8 | ochoa | Cyclin-K | Regulatory subunit of cyclin-dependent kinases that mediates activation of target kinases. Plays a role in transcriptional regulation via its role in regulating the phosphorylation of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A). {ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:9632813}. |
O95379 | TNFAIP8 | S8 | ochoa | Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8) (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein) (NDED) (SCC-S2) (TNF-induced protein GG2-1) | Acts as a negative mediator of apoptosis and may play a role in tumor progression. Suppresses the TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation. {ECO:0000269|PubMed:10644768, ECO:0000269|PubMed:11346652, ECO:0000269|PubMed:14724590}. |
O95786 | RIGI | S8 | ochoa|psp | Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) | Innate immune receptor that senses cytoplasmic viral nucleic acids and activates a downstream signaling cascade leading to the production of type I interferons and pro-inflammatory cytokines (PubMed:15208624, PubMed:15708988, PubMed:16125763, PubMed:16127453, PubMed:16153868, PubMed:17190814, PubMed:18636086, PubMed:19122199, PubMed:19211564, PubMed:24366338, PubMed:28469175, PubMed:29117565, PubMed:31006531, PubMed:34935440, PubMed:35263596, PubMed:36793726). Forms a ribonucleoprotein complex with viral RNAs on which it homooligomerizes to form filaments (PubMed:15208624, PubMed:15708988). The homooligomerization allows the recruitment of RNF135 an E3 ubiquitin-protein ligase that activates and amplifies the RIG-I-mediated antiviral signaling in an RNA length-dependent manner through ubiquitination-dependent and -independent mechanisms (PubMed:28469175, PubMed:31006531). Upon activation, associates with mitochondria antiviral signaling protein (MAVS/IPS1) that activates the IKK-related kinases TBK1 and IKBKE which in turn phosphorylate the interferon regulatory factors IRF3 and IRF7, activating transcription of antiviral immunological genes including the IFN-alpha and IFN-beta interferons (PubMed:28469175, PubMed:31006531). Ligands include 5'-triphosphorylated ssRNAs and dsRNAs but also short dsRNAs (<1 kb in length) (PubMed:15208624, PubMed:15708988, PubMed:19576794, PubMed:19609254, PubMed:21742966). In addition to the 5'-triphosphate moiety, blunt-end base pairing at the 5'-end of the RNA is very essential (PubMed:15208624, PubMed:15708988, PubMed:19576794, PubMed:19609254, PubMed:21742966). Overhangs at the non-triphosphorylated end of the dsRNA RNA have no major impact on its activity (PubMed:15208624, PubMed:15708988, PubMed:19576794, PubMed:19609254, PubMed:21742966). A 3'overhang at the 5'triphosphate end decreases and any 5'overhang at the 5' triphosphate end abolishes its activity (PubMed:15208624, PubMed:15708988, PubMed:19576794, PubMed:19609254, PubMed:21742966). Detects both positive and negative strand RNA viruses including members of the families Paramyxoviridae: Human respiratory syncytial virus and measles virus (MeV), Rhabdoviridae: vesicular stomatitis virus (VSV), Orthomyxoviridae: influenza A and B virus, Flaviviridae: Japanese encephalitis virus (JEV), hepatitis C virus (HCV), dengue virus (DENV) and west Nile virus (WNV) (PubMed:21616437, PubMed:21884169). It also detects rotaviruses and reoviruses (PubMed:21616437, PubMed:21884169). Detects and binds to SARS-CoV-2 RNAs which is inhibited by m6A RNA modifications (Ref.74). Also involved in antiviral signaling in response to viruses containing a dsDNA genome such as Epstein-Barr virus (EBV) (PubMed:19631370). Detects dsRNA produced from non-self dsDNA by RNA polymerase III, such as Epstein-Barr virus-encoded RNAs (EBERs). May play important roles in granulocyte production and differentiation, bacterial phagocytosis and in the regulation of cell migration. {ECO:0000269|PubMed:15208624, ECO:0000269|PubMed:15708988, ECO:0000269|PubMed:16125763, ECO:0000269|PubMed:16127453, ECO:0000269|PubMed:16153868, ECO:0000269|PubMed:17190814, ECO:0000269|PubMed:18636086, ECO:0000269|PubMed:19122199, ECO:0000269|PubMed:19211564, ECO:0000269|PubMed:19576794, ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370, ECO:0000269|PubMed:21742966, ECO:0000269|PubMed:24366338, ECO:0000269|PubMed:28469175, ECO:0000269|PubMed:29117565, ECO:0000269|PubMed:31006531, ECO:0000269|PubMed:34935440, ECO:0000269|PubMed:35263596, ECO:0000269|PubMed:36793726, ECO:0000269|Ref.74, ECO:0000303|PubMed:21616437, ECO:0000303|PubMed:21884169}. |
O96028 | NSD2 | S8 | ochoa | Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) | Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (PubMed:19808676, PubMed:22099308, PubMed:27571355, PubMed:29728617, PubMed:33941880). Also monomethylates nucleosomal histone H3 at 'Lys-36' (H3K36me) in vitro (PubMed:22099308). Does not trimethylate nucleosomal histone H3 at 'Lys-36' (H3K36me3) (PubMed:22099308). However, specifically trimethylates histone H3 at 'Lys-36' (H3K36me3) at euchromatic regions in embryonic stem (ES) cells (By similarity). By methylating histone H3 at 'Lys-36', involved in the regulation of gene transcription during various biological processes (PubMed:16115125, PubMed:22099308, PubMed:29728617). In ES cells, associates with developmental transcription factors such as SALL1 and represses inappropriate gene transcription mediated by histone deacetylation (By similarity). During heart development, associates with transcription factor NKX2-5 to repress transcription of NKX2-5 target genes (By similarity). Plays an essential role in adipogenesis, by regulating expression of genes involved in pre-adipocyte differentiation (PubMed:29728617). During T-cell receptor (TCR) and CD28-mediated T-cell activation, promotes the transcription of transcription factor BCL6 which is required for follicular helper T (Tfh) cell differentiation (By similarity). During B-cell development, required for the generation of the B1 lineage (By similarity). During B2 cell activation, may contribute to the control of isotype class switch recombination (CRS), splenic germinal center formation, and the humoral immune response (By similarity). Plays a role in class switch recombination of the immunoglobulin heavy chain (IgH) locus during B-cell activation (By similarity). By regulating the methylation of histone H3 at 'Lys-36' and histone H4 at 'Lys-20' at the IgH locus, involved in TP53BP1 recruitment to the IgH switch region and promotes the transcription of IgA (By similarity). {ECO:0000250|UniProtKB:Q8BVE8, ECO:0000269|PubMed:16115125, ECO:0000269|PubMed:19808676, ECO:0000269|PubMed:22099308, ECO:0000269|PubMed:27571355, ECO:0000269|PubMed:29728617, ECO:0000269|PubMed:33941880}.; FUNCTION: [Isoform 1]: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2). {ECO:0000269|PubMed:22099308}.; FUNCTION: [Isoform 4]: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (PubMed:22099308). Methylation of histone H3 at 'Lys-27' is controversial (PubMed:18172012, PubMed:22099308). Mono-, di- or tri-methylates histone H3 at 'Lys-27' (H3K27me, H3K27me2 and H3K27me3) (PubMed:18172012). Does not methylate histone H3 at 'Lys-27' (PubMed:22099308). May act as a transcription regulator that binds DNA and suppresses IL5 transcription through HDAC recruitment (PubMed:11152655, PubMed:18172012). {ECO:0000269|PubMed:11152655, ECO:0000269|PubMed:18172012, ECO:0000269|PubMed:22099308}. |
P06454 | PTMA | T8 | ochoa | Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed; Thymosin alpha-1] | Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections. |
P13807 | GYS1 | S8 | ochoa|psp | Glycogen [starch] synthase, muscle (EC 2.4.1.11) (Glycogen synthase 1) | Glycogen synthase participates in the glycogen biosynthetic process along with glycogenin and glycogen branching enzyme. Extends the primer composed of a few glucose units formed by glycogenin by adding new glucose units to it. In this context, glycogen synthase transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan. {ECO:0000269|PubMed:35835870}. |
P19388 | POLR2E | Y8 | ochoa | DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4) | DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase II transcription machinery. Pols are composed of mobile elements that move relative to each other. In Pol II, POLR2E/RPABC1 is part of the lower jaw surrounding the central large cleft and thought to grab the incoming DNA template. {ECO:0000250|UniProtKB:P20434, ECO:0000269|PubMed:16809778, ECO:0000269|PubMed:20413673, ECO:0000269|PubMed:27193682, ECO:0000269|PubMed:30190596, ECO:0000269|PubMed:34671025, ECO:0000269|PubMed:34887565, ECO:0000269|PubMed:36271492, ECO:0000269|PubMed:9852112}. |
P23381 | WARS1 | S8 | ochoa | Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS] | Catalyzes the attachment of tryptophan to tRNA(Trp) in a two-step reaction: tryptophan is first activated by ATP to form Trp-AMP and then transferred to the acceptor end of the tRNA(Trp). {ECO:0000269|PubMed:1373391, ECO:0000269|PubMed:1761529, ECO:0000269|PubMed:28369220}.; FUNCTION: [Isoform 1]: Has no angiostatic activity. {ECO:0000269|PubMed:11773625, ECO:0000269|PubMed:11773626}.; FUNCTION: [T2-TrpRS]: Possesses an angiostatic activity but has no aminoacylation activity (PubMed:11773625, PubMed:11773626, PubMed:14630953). Inhibits fluid shear stress-activated responses of endothelial cells (PubMed:14630953). Regulates ERK, Akt, and eNOS activation pathways that are associated with angiogenesis, cytoskeletal reorganization and shear stress-responsive gene expression (PubMed:14630953). {ECO:0000269|PubMed:11773625, ECO:0000269|PubMed:11773626, ECO:0000269|PubMed:14630953}.; FUNCTION: [Isoform 2]: Has an angiostatic activity. {ECO:0000269|PubMed:11773625, ECO:0000269|PubMed:11773626}. |
P30519 | HMOX2 | S8 | ochoa | Heme oxygenase 2 (HO-2) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 2 soluble form] | [Heme oxygenase 2]: Catalyzes the oxidative cleavage of heme at the alpha-methene bridge carbon, released as carbon monoxide (CO), to generate biliverdin IXalpha, while releasing the central heme iron chelate as ferrous iron. {ECO:0000269|PubMed:1575508, ECO:0000269|PubMed:7890772}.; FUNCTION: [Heme oxygenase 2 soluble form]: Catalyzes the oxidative cleavage of heme at the alpha-methene bridge carbon, released as carbon monoxide (CO), to generate biliverdin IXalpha, while releasing the central heme iron chelate as ferrous iron. {ECO:0000269|PubMed:7890772}. |
P40121 | CAPG | S8 | ochoa | Macrophage-capping protein (Actin regulatory protein CAP-G) | Calcium-sensitive protein which reversibly blocks the barbed ends of actin filaments but does not sever preformed actin filaments. May play an important role in macrophage function. May play a role in regulating cytoplasmic and/or nuclear structures through potential interactions with actin. May bind DNA. |
P50151 | GNG10 | S8 | ochoa | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. Interacts with beta-1 and beta-2, but not with beta-3. |
P55010 | EIF5 | S8 | ochoa | Eukaryotic translation initiation factor 5 (eIF-5) | Component of the 43S pre-initiation complex (43S PIC), which binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated region, and locates the initiation codon (PubMed:11166181, PubMed:22813744, PubMed:24319994). In this complex, acts as a GTPase-activating protein, by promoting GTP hydrolysis by eIF2G (EIF2S3) (PubMed:11166181). During scanning, interacts with both EIF1 (via its C-terminal domain (CTD)) and EIF1A (via its NTD) (PubMed:22813744). This interaction with EIF1A contributes to the maintenance of EIF1 within the open 43S PIC (PubMed:24319994). When start codon is recognized, EIF5, via its NTD, induces eIF2G (EIF2S3) to hydrolyze the GTP (PubMed:11166181). Start codon recognition also induces a conformational change of the PIC to a closed state (PubMed:22813744). This change increases the affinity of EIF5-CTD for EIF2-beta (EIF2S2), which allows the release, by an indirect mechanism, of EIF1 from the PIC (PubMed:22813744). Finally, EIF5 stabilizes the PIC in its closed conformation (PubMed:22813744). {ECO:0000269|PubMed:11166181, ECO:0000269|PubMed:22813744, ECO:0000269|PubMed:24319994}. |
P78362 | SRPK2 | S8 | ochoa | SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] | Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing (PubMed:18559500, PubMed:21056976, PubMed:9472028). Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression (PubMed:19592491). This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression (PubMed:21205200). Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up-regulation (PubMed:18559500). Plays an essential role in spliceosomal B complex formation via the phosphorylation of DDX23/PRP28 (PubMed:18425142). Probably by phosphorylating DDX23, leads to the suppression of incorrect R-loops formed during transcription; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA (PubMed:28076779). Can mediate hepatitis B virus (HBV) core protein phosphorylation (PubMed:12134018). Plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles (PubMed:16122776). {ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:16122776, ECO:0000269|PubMed:18425142, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21056976, ECO:0000269|PubMed:21205200, ECO:0000269|PubMed:28076779, ECO:0000269|PubMed:9472028}. |
Q13615 | MTMR3 | S8 | ochoa | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) | Lipid phosphatase that specifically dephosphorylates the D-3 position of phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate, generating phosphatidylinositol and phosphatidylinositol 5-phosphate (PubMed:10733931, PubMed:11302699, PubMed:11676921, PubMed:12646134). Decreases the levels of phosphatidylinositol 3-phosphate, a phospholipid found in cell membranes where it acts as key regulator of both cell signaling and intracellular membrane traffic (PubMed:11302699, PubMed:11676921, PubMed:12646134). Could also have a molecular sequestering/adapter activity and regulate biological processes independently of its phosphatase activity. It includes the regulation of midbody abscission during mitotic cytokinesis (PubMed:25659891). {ECO:0000269|PubMed:10733931, ECO:0000269|PubMed:11302699, ECO:0000269|PubMed:11676921, ECO:0000269|PubMed:12646134, ECO:0000269|PubMed:25659891}. |
Q14202 | ZMYM3 | S8 | ochoa | Zinc finger MYM-type protein 3 (Zinc finger protein 261) | Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:21834987}. |
Q15020 | SART3 | S8 | ochoa | Spliceosome associated factor 3, U4/U6 recycling protein (Squamous cell carcinoma antigen recognized by T-cells 3) (SART-3) (Tat-interacting protein of 110 kDa) (Tip110) (p110 nuclear RNA-binding protein) | U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation (PubMed:12032085). Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites (PubMed:14749385). May also function as a substrate-targeting factor for deubiquitinases like USP4 and USP15. Recruits USP4 to ubiquitinated PRPF3 within the U4/U5/U6 tri-snRNP complex, promoting PRPF3 deubiquitination and thereby regulating the spliceosome U4/U5/U6 tri-snRNP spliceosomal complex disassembly (PubMed:20595234). May also recruit the deubiquitinase USP15 to histone H2B and mediate histone deubiquitination, thereby regulating gene expression and/or DNA repair (PubMed:24526689). May play a role in hematopoiesis probably through transcription regulation of specific genes including MYC (By similarity). {ECO:0000250|UniProtKB:Q9JLI8, ECO:0000269|PubMed:12032085, ECO:0000269|PubMed:14749385, ECO:0000269|PubMed:20595234, ECO:0000269|PubMed:24526689}.; FUNCTION: Regulates Tat transactivation activity through direct interaction. May be a cellular factor for HIV-1 gene expression and viral replication. {ECO:0000269|PubMed:11959860}. |
Q5T0W9 | FAM83B | S8 | ochoa | Protein FAM83B | Probable proto-oncogene that functions in the epidermal growth factor receptor/EGFR signaling pathway. Activates both the EGFR itself and downstream RAS/MAPK and PI3K/AKT/TOR signaling cascades. {ECO:0000269|PubMed:22886302, ECO:0000269|PubMed:23676467, ECO:0000269|PubMed:23912460}. |
Q86WR7 | PROSER2 | S8 | ochoa | Proline and serine-rich protein 2 | None |
Q8TAA9 | VANGL1 | S8 | ochoa | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | None |
Q8TBE0 | BAHD1 | S8 | ochoa | Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1) | Heterochromatin protein that acts as a transcription repressor and has the ability to promote the formation of large heterochromatic domains. May act by recruiting heterochromatin proteins such as CBX5 (HP1 alpha), HDAC5 and MBD1. Represses IGF2 expression by binding to its CpG-rich P3 promoter and recruiting heterochromatin proteins. At specific stages of Listeria infection, in complex with TRIM28, corepresses interferon-stimulated genes, including IFNL1, IFNL2 and IFNL3. {ECO:0000269|PubMed:19666599, ECO:0000269|PubMed:21252314}. |
Q92613 | JADE3 | S8 | ochoa | Protein Jade-3 (Jade family PHD finger protein 3) (PHD finger protein 16) | Scaffold subunit of some HBO1 complexes, which have a histone H4 acetyltransferase activity. {ECO:0000269|PubMed:16387653}. |
Q96CC6 | RHBDF1 | S8 | ochoa | Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho) | Regulates ADAM17 protease, a sheddase of the epidermal growth factor (EGF) receptor ligands and TNF, thereby plays a role in sleep, cell survival, proliferation, migration and inflammation. Does not exhibit any protease activity on its own. {ECO:0000269|PubMed:15965977, ECO:0000269|PubMed:18524845, ECO:0000269|PubMed:18832597, ECO:0000269|PubMed:21439629}. |
Q96CP6 | GRAMD1A | S8 | ochoa | Protein Aster-A (GRAM domain-containing protein 1A) | Cholesterol transporter that mediates non-vesicular transport of cholesterol from the plasma membrane (PM) to the endoplasmic reticulum (ER) (By similarity). Contains unique domains for binding cholesterol and the PM, thereby serving as a molecular bridge for the transfer of cholesterol from the PM to the ER (By similarity). Plays a crucial role in cholesterol homeostasis and has the unique ability to localize to the PM based on the level of membrane cholesterol (By similarity). In lipid-poor conditions localizes to the ER membrane and in response to excess cholesterol in the PM is recruited to the endoplasmic reticulum-plasma membrane contact sites (EPCS) which is mediated by the GRAM domain (By similarity). At the EPCS, the sterol-binding VASt/ASTER domain binds to the cholesterol in the PM and facilitates its transfer from the PM to ER (By similarity). May play a role in tumor progression (By similarity). Plays a role in autophagy regulation and is required for biogenesis of the autophagosome (PubMed:31222192). This function in autophagy requires its cholesterol-transfer activity (PubMed:31222192). {ECO:0000250|UniProtKB:Q8VEF1, ECO:0000269|PubMed:31222192}. |
Q96MY1 | NOL4L | S8 | ochoa | Nucleolar protein 4-like | None |
Q9C004 | SPRY4 | S8 | ochoa | Protein sprouty homolog 4 (Spry-4) | Suppresses the insulin receptor and EGFR-transduced MAPK signaling pathway, but does not inhibit MAPK activation by a constitutively active mutant Ras (PubMed:12027893). Probably impairs the formation of GTP-Ras (PubMed:12027893). Inhibits Ras-independent, but not Ras-dependent, activation of RAF1 (PubMed:12717443). Represses integrin-mediated cell spreading via inhibition of TESK1-mediated phosphorylation of cofilin (PubMed:15584898). {ECO:0000269|PubMed:12027893, ECO:0000269|PubMed:12717443, ECO:0000269|PubMed:15584898}. |
Q9H3R0 | KDM4C | S8 | ochoa | Lysine-specific demethylase 4C (EC 1.14.11.66) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C) | Histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. {ECO:0000269|PubMed:16603238, ECO:0000269|PubMed:28262558}. |
Q9H8E8 | KAT14 | S8 | ochoa | Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14) | Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. May function as a scaffold for the ATAC complex to promote ATAC complex stability. Has also weak histone acetyltransferase activity toward histone H4. Required for the normal progression through G1 and G2/M phases of the cell cycle. {ECO:0000269|PubMed:19103755}. |
Q9HCS7 | XAB2 | S8 | ochoa | Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) | Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28076346, PubMed:28502770). Involved in transcription-coupled repair (TCR), transcription and pre-mRNA splicing (PubMed:10944529, PubMed:17981804). {ECO:0000269|PubMed:10944529, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:17981804, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}. |
Q9NUJ3 | TCP11L1 | S8 | ochoa | T-complex protein 11-like protein 1 | None |
Q9NWZ3 | IRAK4 | S8 | psp | Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) | Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}. |
Q9NYA4 | MTMR4 | S8 | ochoa | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR4 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 2) (FYVE-DSP2) (Myotubularin-related protein 4) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Zinc finger FYVE domain-containing protein 11) | Lipid phosphatase that specifically dephosphorylates the D-3 position of phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate, generating phosphatidylinositol and phosphatidylinositol 5-phosphate (PubMed:11302699, PubMed:16787938, PubMed:20736309, PubMed:27625994, PubMed:29962048, PubMed:30944173). Decreases the levels of phosphatidylinositol 3-phosphate, a phospholipid found in cell membranes where it acts as key regulator of both cell signaling and intracellular membrane traffic, in a subset of endosomal membranes to negatively regulate both endocytic recycling and trafficking and/or maturation of endosomes toward lysosomes (PubMed:16787938, PubMed:20736309, PubMed:29962048). Through phosphatidylinositol 3-phosphate turnover in phagosome membranes regulates phagocytosis and phagosome maturation (PubMed:31543504). By decreasing phosphatidylinositol 3-monophosphate (PI3P) levels in immune cells it can also regulate the innate immune response (PubMed:30944173). Beside its lipid phosphatase activity, can also function as a molecular adapter to regulate midbody abscission during mitotic cytokinesis (PubMed:25659891). Can also negatively regulate TGF-beta and BMP signaling through Smad proteins dephosphorylation and retention in endosomes (PubMed:20061380, PubMed:23150675). {ECO:0000269|PubMed:11302699, ECO:0000269|PubMed:16787938, ECO:0000269|PubMed:20061380, ECO:0000269|PubMed:20736309, ECO:0000269|PubMed:23150675, ECO:0000269|PubMed:25659891, ECO:0000269|PubMed:27625994, ECO:0000269|PubMed:29962048, ECO:0000269|PubMed:30944173, ECO:0000269|PubMed:31543504}. |
Q9NZT2 | OGFR | S8 | ochoa | Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor) | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation. |
Q9UMX3 | BOK | S8 | ochoa | Bcl-2-related ovarian killer protein (hBOK) (Bcl-2-like protein 9) (Bcl2-L-9) | [Isoform 1]: Apoptosis regulator that functions through different apoptotic signaling pathways (PubMed:15102863, PubMed:20673843, PubMed:27076518). Plays a roles as pro-apoptotic protein that positively regulates intrinsic apoptotic process in a BAX- and BAK1-dependent manner or in a BAX- and BAK1-independent manner (PubMed:15102863, PubMed:27076518). In response to endoplasmic reticulum stress promotes mitochondrial apoptosis through downstream BAX/BAK1 activation and positive regulation of PERK-mediated unfolded protein response (By similarity). Activates apoptosis independently of heterodimerization with survival-promoting BCL2 and BCL2L1 through induction of mitochondrial outer membrane permeabilization, in a BAX- and BAK1-independent manner, in response to inhibition of ERAD-proteasome degradation system, resulting in cytochrome c release (PubMed:27076518). In response to DNA damage, mediates intrinsic apoptotic process in a TP53-dependent manner (PubMed:15102863). Plays a role in granulosa cell apoptosis by CASP3 activation (PubMed:20673843). Plays a roles as anti-apoptotic protein during neuronal apoptotic process, by negatively regulating poly ADP-ribose polymerase-dependent cell death through regulation of neuronal calcium homeostasis and mitochondrial bioenergetics in response to NMDA excitation (By similarity). In addition to its role in apoptosis, may regulate trophoblast cell proliferation during the early stages of placental development, by acting on G1/S transition through regulation of CCNE1 expression (PubMed:19942931). May also play a role as an inducer of autophagy by disrupting interaction between MCL1 and BECN1 (PubMed:24113155). {ECO:0000250|UniProtKB:O35425, ECO:0000269|PubMed:15102863, ECO:0000269|PubMed:19942931, ECO:0000269|PubMed:20673843, ECO:0000269|PubMed:24113155, ECO:0000269|PubMed:27076518}.; FUNCTION: [Isoform 2]: Pro-apoptotic molecule exerting its function through the mitochondrial pathway. {ECO:0000269|PubMed:15775999}. |
Q9Y241 | HIGD1A | S8 | ochoa | HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a) | Proposed subunit of cytochrome c oxidase (COX, complex IV), which is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. May play a role in the assembly of respiratory supercomplexes. {ECO:0000269|PubMed:22342701}. |
Q9Y287 | ITM2B | S8 | ochoa | Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)] | Plays a regulatory role in the processing of the amyloid-beta A4 precursor protein (APP) and acts as an inhibitor of the amyloid-beta peptide aggregation and fibrils deposition. Plays a role in the induction of neurite outgrowth. Functions as a protease inhibitor by blocking access of secretases to APP cleavage sites.; FUNCTION: Mature BRI2 (mBRI2) functions as a modulator of the amyloid-beta A4 precursor protein (APP) processing leading to a strong reduction in the secretion of secretase-processed amyloid-beta protein 40 and amyloid-beta protein 42.; FUNCTION: Bri23 peptide prevents aggregation of APP amyloid-beta protein 42 into toxic oligomers. |
P61024 | CKS1B | Y8 | Sugiyama | Cyclin-dependent kinases regulatory subunit 1 (CKS-1) | Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function. |
P21108 | PRPS1L1 | S8 | Sugiyama | Ribose-phosphate pyrophosphokinase 3 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 1-like 1) (PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III) (PRS-III) | Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis. |
P60891 | PRPS1 | S8 | Sugiyama | Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase I) (PRS-I) | Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis. {ECO:0000269|PubMed:16939420, ECO:0000269|PubMed:17701900, ECO:0000269|PubMed:7593598}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-73843 | 5-Phosphoribose 1-diphosphate biosynthesis | 0.000612 | 3.213 |
R-HSA-1483255 | PI Metabolism | 0.000369 | 3.433 |
R-HSA-1234158 | Regulation of gene expression by Hypoxia-inducible Factor | 0.000951 | 3.022 |
R-HSA-1660517 | Synthesis of PIPs at the late endosome membrane | 0.002019 | 2.695 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.002202 | 2.657 |
R-HSA-3814836 | Glycogen storage disease type XV (GYG1) | 0.011854 | 1.926 |
R-HSA-3828062 | Glycogen storage disease type 0 (muscle GYS1) | 0.011854 | 1.926 |
R-HSA-5603037 | IRAK4 deficiency (TLR5) | 0.014796 | 1.830 |
R-HSA-9833576 | CDH11 homotypic and heterotypic interactions | 0.023570 | 1.628 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 0.026478 | 1.577 |
R-HSA-3785653 | Myoclonic epilepsy of Lafora | 0.032268 | 1.491 |
R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 0.040890 | 1.388 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.043747 | 1.359 |
R-HSA-167287 | HIV elongation arrest and recovery | 0.004714 | 2.327 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 0.004714 | 2.327 |
R-HSA-8964315 | G beta:gamma signalling through BTK | 0.055093 | 1.259 |
R-HSA-73780 | RNA Polymerase III Chain Elongation | 0.055093 | 1.259 |
R-HSA-418217 | G beta:gamma signalling through PLC beta | 0.066307 | 1.178 |
R-HSA-73980 | RNA Polymerase III Transcription Termination | 0.066307 | 1.178 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 0.008790 | 2.056 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 0.069090 | 1.161 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 0.011451 | 1.941 |
R-HSA-5603041 | IRAK4 deficiency (TLR2/4) | 0.077391 | 1.111 |
R-HSA-6803529 | FGFR2 alternative splicing | 0.080141 | 1.096 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 0.082884 | 1.082 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 0.082884 | 1.082 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.013979 | 1.855 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.014421 | 1.841 |
R-HSA-997272 | Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 0.088346 | 1.054 |
R-HSA-1296059 | G protein gated Potassium channels | 0.088346 | 1.054 |
R-HSA-1296041 | Activation of G protein gated Potassium channels | 0.088346 | 1.054 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.015785 | 1.802 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 0.015785 | 1.802 |
R-HSA-6782135 | Dual incision in TC-NER | 0.016724 | 1.777 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 0.093775 | 1.028 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 0.093775 | 1.028 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 0.096478 | 1.016 |
R-HSA-113418 | Formation of the Early Elongation Complex | 0.096478 | 1.016 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 0.025619 | 1.591 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.120451 | 0.919 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 0.136086 | 0.866 |
R-HSA-167161 | HIV Transcription Initiation | 0.136086 | 0.866 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 0.136086 | 0.866 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 0.141237 | 0.850 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 0.146358 | 0.835 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.148907 | 0.827 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 0.164047 | 0.785 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 0.166544 | 0.778 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.132698 | 0.877 |
R-HSA-72172 | mRNA Splicing | 0.143851 | 0.842 |
R-HSA-167172 | Transcription of the HIV genome | 0.021764 | 1.662 |
R-HSA-167169 | HIV Transcription Elongation | 0.130905 | 0.883 |
R-HSA-72086 | mRNA Capping | 0.099173 | 1.004 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 0.130905 | 0.883 |
R-HSA-8964616 | G beta:gamma signalling through CDC42 | 0.060716 | 1.217 |
R-HSA-202040 | G-protein activation | 0.074632 | 1.127 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.032817 | 1.484 |
R-HSA-9762292 | Regulation of CDH11 function | 0.038024 | 1.420 |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | 0.040890 | 1.388 |
R-HSA-397795 | G-protein beta:gamma signalling | 0.109874 | 0.959 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 0.128303 | 0.892 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.101860 | 0.992 |
R-HSA-392170 | ADP signalling through P2Y purinoceptor 12 | 0.074632 | 1.127 |
R-HSA-428930 | Thromboxane signalling through TP receptor | 0.085619 | 1.067 |
R-HSA-73863 | RNA Polymerase I Transcription Termination | 0.093775 | 1.028 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.120451 | 0.919 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.025052 | 1.601 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 0.104539 | 0.981 |
R-HSA-400042 | Adrenaline,noradrenaline inhibits insulin secretion | 0.091064 | 1.041 |
R-HSA-392518 | Signal amplification | 0.115178 | 0.939 |
R-HSA-975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 0.060716 | 1.217 |
R-HSA-392851 | Prostacyclin signalling through prostacyclin receptor | 0.069090 | 1.161 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 0.130905 | 0.883 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.082510 | 1.083 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 0.143801 | 0.842 |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | 0.060716 | 1.217 |
R-HSA-933541 | TRAF6 mediated IRF7 activation | 0.123076 | 0.910 |
R-HSA-68689 | CDC6 association with the ORC:origin complex | 0.023570 | 1.628 |
R-HSA-500657 | Presynaptic function of Kainate receptors | 0.066307 | 1.178 |
R-HSA-8851708 | Signaling by FGFR2 IIIa TM | 0.069090 | 1.161 |
R-HSA-3322077 | Glycogen synthesis | 0.071865 | 1.143 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 0.077391 | 1.111 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 0.080141 | 1.096 |
R-HSA-392451 | G beta:gamma signalling through PI3Kgamma | 0.082884 | 1.082 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.085619 | 1.067 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 0.138666 | 0.858 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.101860 | 0.992 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.047776 | 1.321 |
R-HSA-418592 | ADP signalling through P2Y purinoceptor 1 | 0.085619 | 1.067 |
R-HSA-1296065 | Inwardly rectifying K+ channels | 0.107211 | 0.970 |
R-HSA-3229121 | Glycogen storage diseases | 0.063516 | 1.197 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 0.080141 | 1.096 |
R-HSA-9634597 | GPER1 signaling | 0.153983 | 0.813 |
R-HSA-162587 | HIV Life Cycle | 0.096020 | 1.018 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.057576 | 1.240 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.057576 | 1.240 |
R-HSA-456926 | Thrombin signalling through proteinase activated receptors (PARs) | 0.101860 | 0.992 |
R-HSA-991365 | Activation of GABAB receptors | 0.138666 | 0.858 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 0.063516 | 1.197 |
R-HSA-381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 0.138666 | 0.858 |
R-HSA-977444 | GABA B receptor activation | 0.138666 | 0.858 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 0.148907 | 0.827 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.049978 | 1.301 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.077391 | 1.111 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.153983 | 0.813 |
R-HSA-8982491 | Glycogen metabolism | 0.130905 | 0.883 |
R-HSA-162906 | HIV Infection | 0.167771 | 0.775 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 0.099173 | 1.004 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.133500 | 0.875 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 0.109874 | 0.959 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 0.109874 | 0.959 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 0.069090 | 1.161 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 0.130905 | 0.883 |
R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production | 0.146358 | 0.835 |
R-HSA-68949 | Orc1 removal from chromatin | 0.164047 | 0.785 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.133500 | 0.875 |
R-HSA-176187 | Activation of ATR in response to replication stress | 0.109874 | 0.959 |
R-HSA-9764302 | Regulation of CDH19 Expression and Function | 0.023570 | 1.628 |
R-HSA-391160 | Signal regulatory protein family interactions | 0.052269 | 1.282 |
R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins | 0.146358 | 0.835 |
R-HSA-9766229 | Degradation of CDH1 | 0.156510 | 0.805 |
R-HSA-69206 | G1/S Transition | 0.065549 | 1.183 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.018672 | 1.729 |
R-HSA-6814122 | Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 0.115178 | 0.939 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 0.133500 | 0.875 |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | 0.096478 | 1.016 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 0.104539 | 0.981 |
R-HSA-163359 | Glucagon signaling in metabolic regulation | 0.112530 | 0.949 |
R-HSA-69481 | G2/M Checkpoints | 0.067186 | 1.173 |
R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane | 0.088346 | 1.054 |
R-HSA-1855183 | Synthesis of IP2, IP, and Ins in the cytosol | 0.091064 | 1.041 |
R-HSA-5260271 | Diseases of Immune System | 0.130905 | 0.883 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.130905 | 0.883 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.086051 | 1.065 |
R-HSA-3214847 | HATs acetylate histones | 0.042784 | 1.369 |
R-HSA-73894 | DNA Repair | 0.104093 | 0.983 |
R-HSA-203927 | MicroRNA (miRNA) biogenesis | 0.088346 | 1.054 |
R-HSA-420092 | Glucagon-type ligand receptors | 0.099173 | 1.004 |
R-HSA-3214842 | HDMs demethylate histones | 0.088346 | 1.054 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.143801 | 0.842 |
R-HSA-69236 | G1 Phase | 0.143801 | 0.842 |
R-HSA-9864848 | Complex IV assembly | 0.161542 | 0.792 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.006935 | 2.159 |
R-HSA-71336 | Pentose phosphate pathway | 0.008436 | 2.074 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.030338 | 1.518 |
R-HSA-69242 | S Phase | 0.087839 | 1.056 |
R-HSA-4839726 | Chromatin organization | 0.008446 | 2.073 |
R-HSA-9694631 | Maturation of nucleoprotein | 0.069090 | 1.161 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 0.080141 | 1.096 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.123076 | 0.910 |
R-HSA-72766 | Translation | 0.150285 | 0.823 |
R-HSA-8983711 | OAS antiviral response | 0.046596 | 1.332 |
R-HSA-5601884 | PIWI-interacting RNA (piRNA) biogenesis | 0.088346 | 1.054 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.117819 | 0.929 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 0.133500 | 0.875 |
R-HSA-1839126 | FGFR2 mutant receptor activation | 0.120451 | 0.919 |
R-HSA-1483257 | Phospholipid metabolism | 0.014383 | 1.842 |
R-HSA-1640170 | Cell Cycle | 0.065114 | 1.186 |
R-HSA-1234174 | Cellular response to hypoxia | 0.020193 | 1.695 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 0.138666 | 0.858 |
R-HSA-189483 | Heme degradation | 0.112530 | 0.949 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 0.141237 | 0.850 |
R-HSA-611105 | Respiratory electron transport | 0.116872 | 0.932 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 0.123076 | 0.910 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 0.159030 | 0.799 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 0.164047 | 0.785 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.056525 | 1.248 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.041397 | 1.383 |
R-HSA-9006936 | Signaling by TGFB family members | 0.098794 | 1.005 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.168916 | 0.772 |
R-HSA-72649 | Translation initiation complex formation | 0.169034 | 0.772 |
R-HSA-418597 | G alpha (z) signalling events | 0.171517 | 0.766 |
R-HSA-177929 | Signaling by EGFR | 0.173993 | 0.759 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.173993 | 0.759 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.176461 | 0.753 |
R-HSA-8939211 | ESR-mediated signaling | 0.178383 | 0.749 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.178923 | 0.747 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.181376 | 0.741 |
R-HSA-977443 | GABA receptor activation | 0.183823 | 0.736 |
R-HSA-379724 | tRNA Aminoacylation | 0.183823 | 0.736 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.186263 | 0.730 |
R-HSA-445717 | Aquaporin-mediated transport | 0.186263 | 0.730 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.200751 | 0.697 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.200994 | 0.697 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.207900 | 0.682 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.207900 | 0.682 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.210270 | 0.677 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.210270 | 0.677 |
R-HSA-189445 | Metabolism of porphyrins | 0.210270 | 0.677 |
R-HSA-9711123 | Cellular response to chemical stress | 0.211885 | 0.674 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.212632 | 0.672 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.212632 | 0.672 |
R-HSA-4086398 | Ca2+ pathway | 0.214987 | 0.668 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.214987 | 0.668 |
R-HSA-5663084 | Diseases of carbohydrate metabolism | 0.214987 | 0.668 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.217335 | 0.663 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.217335 | 0.663 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.219677 | 0.658 |
R-HSA-917937 | Iron uptake and transport | 0.219677 | 0.658 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 0.222011 | 0.654 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.223936 | 0.650 |
R-HSA-9694635 | Translation of Structural Proteins | 0.224339 | 0.649 |
R-HSA-73864 | RNA Polymerase I Transcription | 0.226660 | 0.645 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.226660 | 0.645 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 0.231282 | 0.636 |
R-HSA-5654738 | Signaling by FGFR2 | 0.231282 | 0.636 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.231282 | 0.636 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.233582 | 0.632 |
R-HSA-977225 | Amyloid fiber formation | 0.233582 | 0.632 |
R-HSA-390466 | Chaperonin-mediated protein folding | 0.249499 | 0.603 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.254677 | 0.594 |
R-HSA-373080 | Class B/2 (Secretin family receptors) | 0.256221 | 0.591 |
R-HSA-391251 | Protein folding | 0.262884 | 0.580 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.262884 | 0.580 |
R-HSA-1500931 | Cell-Cell communication | 0.264805 | 0.577 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.265092 | 0.577 |
R-HSA-8953897 | Cellular responses to stimuli | 0.266083 | 0.575 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.269488 | 0.569 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.271677 | 0.566 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.272563 | 0.565 |
R-HSA-1296071 | Potassium Channels | 0.273859 | 0.562 |
R-HSA-157579 | Telomere Maintenance | 0.276035 | 0.559 |
R-HSA-422356 | Regulation of insulin secretion | 0.278204 | 0.556 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.278204 | 0.556 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.278204 | 0.556 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.278204 | 0.556 |
R-HSA-190236 | Signaling by FGFR | 0.278204 | 0.556 |
R-HSA-9020702 | Interleukin-1 signaling | 0.284674 | 0.546 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 0.284674 | 0.546 |
R-HSA-111885 | Opioid Signalling | 0.291087 | 0.536 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.291087 | 0.536 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.292504 | 0.534 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.292894 | 0.533 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.293213 | 0.533 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.293213 | 0.533 |
R-HSA-9833110 | RSV-host interactions | 0.293213 | 0.533 |
R-HSA-418346 | Platelet homeostasis | 0.297444 | 0.527 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.297444 | 0.527 |
R-HSA-211000 | Gene Silencing by RNA | 0.299551 | 0.524 |
R-HSA-69239 | Synthesis of DNA | 0.299551 | 0.524 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.301353 | 0.521 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.301651 | 0.520 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.301651 | 0.520 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.303746 | 0.517 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.303746 | 0.517 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.309991 | 0.509 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.312061 | 0.506 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.314125 | 0.503 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.314125 | 0.503 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.316799 | 0.499 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.318234 | 0.497 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 0.318234 | 0.497 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.320279 | 0.494 |
R-HSA-5693538 | Homology Directed Repair | 0.326380 | 0.486 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.328401 | 0.484 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.328401 | 0.484 |
R-HSA-73886 | Chromosome Maintenance | 0.332426 | 0.478 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.334430 | 0.476 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.334430 | 0.476 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.336428 | 0.473 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.336428 | 0.473 |
R-HSA-194138 | Signaling by VEGF | 0.342387 | 0.465 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.352201 | 0.453 |
R-HSA-163685 | Integration of energy metabolism | 0.367607 | 0.435 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.367607 | 0.435 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.367607 | 0.435 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.369507 | 0.432 |
R-HSA-2262752 | Cellular responses to stress | 0.375159 | 0.426 |
R-HSA-1632852 | Macroautophagy | 0.377053 | 0.424 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.380793 | 0.419 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.391880 | 0.407 |
R-HSA-446652 | Interleukin-1 family signaling | 0.399163 | 0.399 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.400970 | 0.397 |
R-HSA-69306 | DNA Replication | 0.400970 | 0.397 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.402773 | 0.395 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.402773 | 0.395 |
R-HSA-5663205 | Infectious disease | 0.402997 | 0.395 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.404569 | 0.393 |
R-HSA-9612973 | Autophagy | 0.406361 | 0.391 |
R-HSA-162582 | Signal Transduction | 0.425060 | 0.372 |
R-HSA-418555 | G alpha (s) signalling events | 0.434317 | 0.362 |
R-HSA-5689880 | Ub-specific processing proteases | 0.437720 | 0.359 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.437720 | 0.359 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.437720 | 0.359 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.437720 | 0.359 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.437720 | 0.359 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.441102 | 0.355 |
R-HSA-168255 | Influenza Infection | 0.447808 | 0.349 |
R-HSA-9824446 | Viral Infection Pathways | 0.449813 | 0.347 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.467455 | 0.330 |
R-HSA-68877 | Mitotic Prometaphase | 0.470662 | 0.327 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.475438 | 0.323 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.501713 | 0.300 |
R-HSA-418990 | Adherens junctions interactions | 0.510675 | 0.292 |
R-HSA-9679506 | SARS-CoV Infections | 0.516027 | 0.287 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.525262 | 0.280 |
R-HSA-421270 | Cell-cell junction organization | 0.557216 | 0.254 |
R-HSA-5688426 | Deubiquitination | 0.562555 | 0.250 |
R-HSA-416476 | G alpha (q) signalling events | 0.574336 | 0.241 |
R-HSA-168249 | Innate Immune System | 0.579963 | 0.237 |
R-HSA-1430728 | Metabolism | 0.585504 | 0.232 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.587062 | 0.231 |
R-HSA-446728 | Cell junction organization | 0.592047 | 0.228 |
R-HSA-9658195 | Leishmania infection | 0.595748 | 0.225 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.595748 | 0.225 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.612586 | 0.213 |
R-HSA-195721 | Signaling by WNT | 0.616104 | 0.210 |
R-HSA-1643685 | Disease | 0.634635 | 0.197 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.644228 | 0.191 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.664243 | 0.178 |
R-HSA-556833 | Metabolism of lipids | 0.669844 | 0.174 |
R-HSA-212436 | Generic Transcription Pathway | 0.702272 | 0.153 |
R-HSA-68886 | M Phase | 0.703751 | 0.153 |
R-HSA-913531 | Interferon Signaling | 0.704655 | 0.152 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.710911 | 0.148 |
R-HSA-74160 | Gene expression (Transcription) | 0.723164 | 0.141 |
R-HSA-418594 | G alpha (i) signalling events | 0.725567 | 0.139 |
R-HSA-8953854 | Metabolism of RNA | 0.731516 | 0.136 |
R-HSA-5668914 | Diseases of metabolism | 0.741880 | 0.130 |
R-HSA-392499 | Metabolism of proteins | 0.751062 | 0.124 |
R-HSA-6798695 | Neutrophil degranulation | 0.764584 | 0.117 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.766211 | 0.116 |
R-HSA-112316 | Neuronal System | 0.772409 | 0.112 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.803071 | 0.095 |
R-HSA-382551 | Transport of small molecules | 0.808381 | 0.092 |
R-HSA-500792 | GPCR ligand binding | 0.843332 | 0.074 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.846755 | 0.072 |
R-HSA-449147 | Signaling by Interleukins | 0.859885 | 0.066 |
R-HSA-388396 | GPCR downstream signalling | 0.911984 | 0.040 |
R-HSA-109582 | Hemostasis | 0.914702 | 0.039 |
R-HSA-372790 | Signaling by GPCR | 0.932201 | 0.030 |
R-HSA-168256 | Immune System | 0.976420 | 0.010 |
R-HSA-1266738 | Developmental Biology | 0.985270 | 0.006 |
R-HSA-597592 | Post-translational protein modification | 0.994952 | 0.002 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.777 | 0.233 | 1 | 0.698 |
COT |
0.772 | 0.120 | 2 | 0.594 |
SKMLCK |
0.766 | 0.213 | -2 | 0.822 |
GRK1 |
0.766 | 0.152 | -2 | 0.756 |
CDC7 |
0.765 | 0.080 | 1 | 0.641 |
PIM3 |
0.765 | 0.136 | -3 | 0.760 |
MOS |
0.765 | 0.119 | 1 | 0.681 |
BMPR1B |
0.763 | 0.247 | 1 | 0.657 |
KIS |
0.763 | 0.101 | 1 | 0.591 |
IKKB |
0.761 | 0.050 | -2 | 0.675 |
RAF1 |
0.761 | 0.111 | 1 | 0.671 |
FAM20C |
0.759 | 0.086 | 2 | 0.498 |
GRK6 |
0.758 | 0.131 | 1 | 0.649 |
TBK1 |
0.758 | 0.035 | 1 | 0.590 |
CAMK2G |
0.758 | 0.028 | 2 | 0.620 |
HIPK4 |
0.758 | 0.123 | 1 | 0.674 |
PRPK |
0.757 | -0.051 | -1 | 0.784 |
CAMK1B |
0.757 | 0.098 | -3 | 0.791 |
NDR2 |
0.757 | 0.050 | -3 | 0.733 |
IKKA |
0.756 | 0.076 | -2 | 0.647 |
ERK5 |
0.755 | 0.073 | 1 | 0.733 |
IKKE |
0.754 | 0.024 | 1 | 0.589 |
BMPR1A |
0.754 | 0.222 | 1 | 0.618 |
CDKL1 |
0.754 | 0.111 | -3 | 0.742 |
CAMLCK |
0.752 | 0.134 | -2 | 0.823 |
GRK5 |
0.752 | -0.006 | -3 | 0.756 |
TGFBR1 |
0.752 | 0.172 | -2 | 0.780 |
ICK |
0.751 | 0.149 | -3 | 0.757 |
ALK4 |
0.751 | 0.162 | -2 | 0.808 |
MTOR |
0.751 | -0.022 | 1 | 0.629 |
CHAK2 |
0.751 | 0.057 | -1 | 0.827 |
RSK2 |
0.750 | 0.125 | -3 | 0.728 |
GRK7 |
0.750 | 0.152 | 1 | 0.585 |
MARK4 |
0.750 | 0.036 | 4 | 0.812 |
CDKL5 |
0.750 | 0.119 | -3 | 0.733 |
PIM1 |
0.750 | 0.114 | -3 | 0.743 |
CLK2 |
0.749 | 0.206 | -3 | 0.735 |
DAPK2 |
0.749 | 0.138 | -3 | 0.773 |
DYRK2 |
0.749 | 0.113 | 1 | 0.618 |
DSTYK |
0.749 | -0.016 | 2 | 0.612 |
BMPR2 |
0.749 | -0.061 | -2 | 0.797 |
SRPK1 |
0.749 | 0.084 | -3 | 0.726 |
ATR |
0.748 | -0.026 | 1 | 0.602 |
GRK4 |
0.748 | 0.003 | -2 | 0.757 |
NLK |
0.748 | 0.003 | 1 | 0.692 |
PAK1 |
0.747 | 0.121 | -2 | 0.795 |
CLK4 |
0.746 | 0.171 | -3 | 0.743 |
MYLK4 |
0.746 | 0.165 | -2 | 0.771 |
HIPK2 |
0.746 | 0.125 | 1 | 0.553 |
AURA |
0.746 | 0.184 | -2 | 0.680 |
GCN2 |
0.746 | -0.164 | 2 | 0.571 |
HUNK |
0.746 | -0.044 | 2 | 0.597 |
MSK1 |
0.746 | 0.173 | -3 | 0.702 |
AURC |
0.745 | 0.162 | -2 | 0.693 |
PKACG |
0.745 | 0.103 | -2 | 0.732 |
PDHK4 |
0.745 | -0.192 | 1 | 0.675 |
RIPK3 |
0.744 | -0.018 | 3 | 0.640 |
ACVR2B |
0.744 | 0.145 | -2 | 0.750 |
NDR1 |
0.744 | 0.012 | -3 | 0.744 |
DYRK4 |
0.744 | 0.135 | 1 | 0.556 |
PRKX |
0.744 | 0.188 | -3 | 0.664 |
PKACB |
0.744 | 0.171 | -2 | 0.687 |
LATS2 |
0.743 | 0.034 | -5 | 0.621 |
LATS1 |
0.743 | 0.132 | -3 | 0.735 |
ALK2 |
0.743 | 0.144 | -2 | 0.786 |
PLK1 |
0.743 | 0.052 | -2 | 0.716 |
P90RSK |
0.743 | 0.072 | -3 | 0.721 |
CAMK2B |
0.742 | 0.069 | 2 | 0.596 |
PRKD1 |
0.742 | 0.037 | -3 | 0.714 |
ATM |
0.742 | -0.013 | 1 | 0.525 |
ACVR2A |
0.742 | 0.117 | -2 | 0.747 |
PKN3 |
0.742 | -0.006 | -3 | 0.735 |
CAMK2A |
0.742 | 0.089 | 2 | 0.609 |
WNK1 |
0.741 | -0.023 | -2 | 0.804 |
MSK2 |
0.741 | 0.108 | -3 | 0.695 |
RSK4 |
0.741 | 0.134 | -3 | 0.691 |
TGFBR2 |
0.741 | -0.011 | -2 | 0.773 |
NUAK2 |
0.741 | 0.015 | -3 | 0.775 |
AMPKA1 |
0.741 | 0.025 | -3 | 0.761 |
NIK |
0.741 | -0.040 | -3 | 0.777 |
CDK8 |
0.741 | 0.034 | 1 | 0.569 |
GRK2 |
0.740 | 0.057 | -2 | 0.661 |
SRPK2 |
0.740 | 0.075 | -3 | 0.664 |
P38B |
0.740 | 0.107 | 1 | 0.580 |
MLK1 |
0.740 | -0.095 | 2 | 0.532 |
PAK2 |
0.740 | 0.096 | -2 | 0.793 |
P70S6KB |
0.740 | 0.058 | -3 | 0.741 |
PDHK1 |
0.740 | -0.173 | 1 | 0.662 |
PLK3 |
0.740 | 0.035 | 2 | 0.614 |
TSSK2 |
0.740 | 0.017 | -5 | 0.637 |
PAK3 |
0.739 | 0.067 | -2 | 0.783 |
PASK |
0.739 | 0.193 | -3 | 0.756 |
QSK |
0.739 | 0.057 | 4 | 0.788 |
PRKD2 |
0.738 | 0.068 | -3 | 0.701 |
MASTL |
0.738 | -0.152 | -2 | 0.755 |
WNK3 |
0.738 | -0.116 | 1 | 0.638 |
RSK3 |
0.738 | 0.064 | -3 | 0.720 |
DLK |
0.738 | -0.030 | 1 | 0.634 |
ANKRD3 |
0.738 | -0.057 | 1 | 0.663 |
MARK3 |
0.737 | 0.068 | 4 | 0.767 |
TLK2 |
0.737 | 0.026 | 1 | 0.619 |
JNK3 |
0.737 | 0.075 | 1 | 0.562 |
ULK2 |
0.737 | -0.215 | 2 | 0.545 |
DYRK1A |
0.737 | 0.116 | 1 | 0.618 |
AURB |
0.737 | 0.141 | -2 | 0.693 |
JNK2 |
0.737 | 0.085 | 1 | 0.543 |
BRSK1 |
0.736 | 0.041 | -3 | 0.723 |
CDK1 |
0.736 | 0.067 | 1 | 0.563 |
CK2A2 |
0.736 | 0.136 | 1 | 0.572 |
MAPKAPK2 |
0.736 | 0.054 | -3 | 0.678 |
HIPK1 |
0.735 | 0.097 | 1 | 0.630 |
PAK6 |
0.735 | 0.121 | -2 | 0.739 |
NIM1 |
0.735 | -0.068 | 3 | 0.707 |
RIPK1 |
0.735 | -0.088 | 1 | 0.630 |
CLK1 |
0.735 | 0.130 | -3 | 0.726 |
TSSK1 |
0.735 | 0.028 | -3 | 0.771 |
P38A |
0.735 | 0.079 | 1 | 0.636 |
CK1E |
0.735 | 0.058 | -3 | 0.580 |
BCKDK |
0.734 | -0.128 | -1 | 0.695 |
CDK7 |
0.734 | 0.024 | 1 | 0.585 |
ERK1 |
0.734 | 0.069 | 1 | 0.571 |
CAMK2D |
0.734 | -0.044 | -3 | 0.733 |
CDK19 |
0.734 | 0.031 | 1 | 0.547 |
AMPKA2 |
0.734 | 0.020 | -3 | 0.739 |
MARK2 |
0.733 | 0.043 | 4 | 0.737 |
PKN2 |
0.733 | -0.018 | -3 | 0.759 |
MLK3 |
0.733 | -0.065 | 2 | 0.479 |
NEK6 |
0.732 | -0.127 | -2 | 0.750 |
PKCD |
0.732 | -0.010 | 2 | 0.511 |
MLK4 |
0.732 | -0.045 | 2 | 0.478 |
NEK7 |
0.732 | -0.184 | -3 | 0.646 |
MEK1 |
0.732 | -0.061 | 2 | 0.604 |
GRK3 |
0.731 | 0.051 | -2 | 0.632 |
DYRK3 |
0.731 | 0.133 | 1 | 0.628 |
MST4 |
0.731 | -0.073 | 2 | 0.543 |
SRPK3 |
0.731 | 0.028 | -3 | 0.701 |
CAMK4 |
0.731 | -0.011 | -3 | 0.746 |
DYRK1B |
0.731 | 0.081 | 1 | 0.591 |
P38G |
0.730 | 0.055 | 1 | 0.492 |
ERK2 |
0.730 | 0.038 | 1 | 0.595 |
P38D |
0.730 | 0.086 | 1 | 0.490 |
SIK |
0.730 | 0.022 | -3 | 0.705 |
ULK1 |
0.730 | -0.188 | -3 | 0.639 |
PKACA |
0.730 | 0.153 | -2 | 0.641 |
MARK1 |
0.729 | 0.032 | 4 | 0.777 |
PIM2 |
0.729 | 0.078 | -3 | 0.712 |
MAPKAPK3 |
0.729 | -0.019 | -3 | 0.697 |
CK2A1 |
0.729 | 0.128 | 1 | 0.554 |
DRAK1 |
0.729 | 0.047 | 1 | 0.587 |
CK1D |
0.728 | 0.063 | -3 | 0.538 |
TTBK2 |
0.728 | -0.155 | 2 | 0.504 |
PLK2 |
0.728 | 0.092 | -3 | 0.694 |
IRE1 |
0.727 | -0.118 | 1 | 0.648 |
HIPK3 |
0.727 | 0.069 | 1 | 0.621 |
DNAPK |
0.727 | -0.020 | 1 | 0.497 |
MLK2 |
0.726 | -0.170 | 2 | 0.551 |
PKG2 |
0.726 | 0.091 | -2 | 0.679 |
PRKD3 |
0.726 | 0.031 | -3 | 0.707 |
AKT2 |
0.726 | 0.104 | -3 | 0.683 |
BRSK2 |
0.726 | -0.022 | -3 | 0.730 |
QIK |
0.726 | -0.061 | -3 | 0.736 |
PINK1 |
0.725 | -0.056 | 1 | 0.702 |
CK1A2 |
0.725 | 0.057 | -3 | 0.548 |
TLK1 |
0.725 | -0.019 | -2 | 0.745 |
CDK13 |
0.725 | -0.014 | 1 | 0.563 |
VRK2 |
0.725 | -0.167 | 1 | 0.685 |
CDK18 |
0.725 | 0.033 | 1 | 0.539 |
SNRK |
0.725 | -0.076 | 2 | 0.551 |
PLK4 |
0.725 | -0.083 | 2 | 0.518 |
IRE2 |
0.725 | -0.099 | 2 | 0.510 |
MELK |
0.724 | -0.025 | -3 | 0.725 |
SMG1 |
0.724 | -0.071 | 1 | 0.558 |
YSK4 |
0.724 | -0.081 | 1 | 0.603 |
MEKK3 |
0.724 | -0.046 | 1 | 0.631 |
PKR |
0.724 | -0.095 | 1 | 0.684 |
JNK1 |
0.724 | 0.070 | 1 | 0.530 |
PRP4 |
0.723 | -0.000 | -3 | 0.636 |
MNK2 |
0.723 | 0.033 | -2 | 0.763 |
GAK |
0.723 | 0.153 | 1 | 0.720 |
SGK3 |
0.723 | 0.063 | -3 | 0.710 |
DAPK1 |
0.723 | 0.167 | -3 | 0.745 |
SMMLCK |
0.723 | 0.089 | -3 | 0.753 |
DAPK3 |
0.723 | 0.144 | -3 | 0.749 |
NUAK1 |
0.723 | -0.028 | -3 | 0.725 |
GSK3A |
0.722 | 0.054 | 4 | 0.423 |
CAMK1G |
0.722 | 0.026 | -3 | 0.717 |
CDK17 |
0.721 | 0.023 | 1 | 0.496 |
MNK1 |
0.720 | 0.028 | -2 | 0.763 |
CDK5 |
0.720 | -0.005 | 1 | 0.604 |
MAK |
0.720 | 0.172 | -2 | 0.783 |
CHAK1 |
0.720 | -0.133 | 2 | 0.559 |
CHK1 |
0.720 | -0.044 | -3 | 0.711 |
BRAF |
0.720 | -0.068 | -4 | 0.722 |
DCAMKL1 |
0.719 | 0.014 | -3 | 0.728 |
CDK12 |
0.719 | -0.010 | 1 | 0.541 |
PKCZ |
0.719 | -0.051 | 2 | 0.504 |
CK1G1 |
0.718 | 0.005 | -3 | 0.581 |
PKCG |
0.718 | -0.067 | 2 | 0.478 |
SSTK |
0.718 | -0.004 | 4 | 0.774 |
PAK4 |
0.718 | 0.098 | -2 | 0.706 |
CDK14 |
0.717 | 0.042 | 1 | 0.575 |
NEK9 |
0.717 | -0.285 | 2 | 0.539 |
GSK3B |
0.717 | 0.020 | 4 | 0.412 |
MEKK2 |
0.717 | -0.099 | 2 | 0.536 |
CAMK1D |
0.716 | 0.060 | -3 | 0.659 |
CDK3 |
0.716 | 0.031 | 1 | 0.513 |
CDK9 |
0.716 | -0.031 | 1 | 0.570 |
PAK5 |
0.716 | 0.087 | -2 | 0.699 |
PKCB |
0.715 | -0.074 | 2 | 0.452 |
CDK2 |
0.715 | -0.030 | 1 | 0.612 |
DCAMKL2 |
0.715 | -0.004 | -3 | 0.749 |
PKCH |
0.715 | -0.070 | 2 | 0.454 |
MPSK1 |
0.715 | 0.023 | 1 | 0.687 |
MEK5 |
0.714 | -0.198 | 2 | 0.573 |
PERK |
0.713 | -0.174 | -2 | 0.781 |
AKT1 |
0.713 | 0.093 | -3 | 0.685 |
PHKG1 |
0.712 | -0.116 | -3 | 0.742 |
WNK4 |
0.712 | -0.124 | -2 | 0.804 |
TAO3 |
0.712 | -0.050 | 1 | 0.619 |
YANK3 |
0.712 | 0.040 | 2 | 0.354 |
P70S6K |
0.712 | 0.010 | -3 | 0.670 |
PKCA |
0.711 | -0.080 | 2 | 0.454 |
CDK16 |
0.710 | 0.022 | 1 | 0.508 |
MAPKAPK5 |
0.710 | -0.081 | -3 | 0.654 |
MRCKA |
0.709 | 0.115 | -3 | 0.707 |
MST3 |
0.709 | -0.070 | 2 | 0.556 |
SGK1 |
0.709 | 0.104 | -3 | 0.620 |
NEK2 |
0.708 | -0.199 | 2 | 0.538 |
HRI |
0.708 | -0.216 | -2 | 0.775 |
TTBK1 |
0.708 | -0.141 | 2 | 0.466 |
ZAK |
0.708 | -0.189 | 1 | 0.573 |
MEKK1 |
0.706 | -0.227 | 1 | 0.620 |
GCK |
0.706 | 0.025 | 1 | 0.684 |
MRCKB |
0.706 | 0.101 | -3 | 0.705 |
NEK8 |
0.706 | -0.133 | 2 | 0.559 |
TAK1 |
0.706 | 0.012 | 1 | 0.650 |
CDK10 |
0.705 | 0.018 | 1 | 0.566 |
NEK5 |
0.705 | -0.182 | 1 | 0.660 |
PDK1 |
0.705 | -0.074 | 1 | 0.606 |
CHK2 |
0.704 | 0.058 | -3 | 0.649 |
MOK |
0.704 | 0.094 | 1 | 0.670 |
ROCK2 |
0.704 | 0.092 | -3 | 0.728 |
IRAK4 |
0.703 | -0.163 | 1 | 0.636 |
ERK7 |
0.703 | -0.041 | 2 | 0.338 |
AKT3 |
0.703 | 0.093 | -3 | 0.629 |
SBK |
0.703 | 0.075 | -3 | 0.593 |
CK1A |
0.702 | 0.044 | -3 | 0.473 |
LKB1 |
0.701 | -0.112 | -3 | 0.646 |
CAMKK1 |
0.701 | -0.173 | -2 | 0.652 |
NEK11 |
0.701 | -0.156 | 1 | 0.619 |
DMPK1 |
0.701 | 0.130 | -3 | 0.737 |
MST2 |
0.700 | -0.065 | 1 | 0.657 |
PKCT |
0.700 | -0.073 | 2 | 0.456 |
SLK |
0.700 | -0.020 | -2 | 0.670 |
PHKG2 |
0.700 | -0.087 | -3 | 0.752 |
PDHK3_TYR |
0.699 | 0.133 | 4 | 0.826 |
CAMKK2 |
0.699 | -0.143 | -2 | 0.663 |
STK33 |
0.699 | -0.107 | 2 | 0.482 |
MAP2K6_TYR |
0.699 | 0.166 | -1 | 0.796 |
HPK1 |
0.699 | -0.006 | 1 | 0.670 |
IRAK1 |
0.698 | -0.240 | -1 | 0.674 |
CAMK1A |
0.698 | 0.039 | -3 | 0.649 |
PKCI |
0.698 | -0.062 | 2 | 0.468 |
PKCE |
0.697 | -0.021 | 2 | 0.462 |
TAO2 |
0.697 | -0.171 | 2 | 0.565 |
PBK |
0.696 | 0.023 | 1 | 0.682 |
LRRK2 |
0.696 | -0.150 | 2 | 0.591 |
PDHK1_TYR |
0.695 | 0.126 | -1 | 0.817 |
PDHK4_TYR |
0.695 | 0.118 | 2 | 0.669 |
CDK4 |
0.695 | -0.011 | 1 | 0.532 |
MINK |
0.694 | -0.089 | 1 | 0.660 |
PKG1 |
0.694 | 0.069 | -2 | 0.620 |
TNIK |
0.694 | -0.091 | 3 | 0.673 |
MST1 |
0.693 | -0.079 | 1 | 0.645 |
TTK |
0.693 | -0.011 | -2 | 0.750 |
BMPR2_TYR |
0.693 | 0.101 | -1 | 0.794 |
PKN1 |
0.692 | -0.026 | -3 | 0.692 |
CDK6 |
0.692 | -0.026 | 1 | 0.553 |
MAP3K15 |
0.692 | -0.166 | 1 | 0.564 |
ALPHAK3 |
0.692 | 0.034 | -1 | 0.747 |
VRK1 |
0.691 | -0.169 | 2 | 0.571 |
ROCK1 |
0.691 | 0.083 | -3 | 0.711 |
EEF2K |
0.690 | -0.144 | 3 | 0.644 |
MAP2K4_TYR |
0.690 | 0.019 | -1 | 0.784 |
HGK |
0.690 | -0.143 | 3 | 0.673 |
MEKK6 |
0.689 | -0.183 | 1 | 0.633 |
KHS1 |
0.689 | -0.045 | 1 | 0.660 |
NEK4 |
0.689 | -0.203 | 1 | 0.646 |
KHS2 |
0.689 | -0.021 | 1 | 0.677 |
LOK |
0.688 | -0.106 | -2 | 0.709 |
MAP2K7_TYR |
0.688 | -0.099 | 2 | 0.645 |
EPHA6 |
0.688 | 0.054 | -1 | 0.808 |
CRIK |
0.688 | 0.061 | -3 | 0.672 |
BUB1 |
0.688 | -0.016 | -5 | 0.542 |
TESK1_TYR |
0.687 | -0.095 | 3 | 0.758 |
MEK2 |
0.686 | -0.219 | 2 | 0.564 |
RIPK2 |
0.686 | -0.225 | 1 | 0.533 |
EPHA4 |
0.685 | 0.051 | 2 | 0.635 |
EPHB4 |
0.684 | 0.031 | -1 | 0.787 |
PKMYT1_TYR |
0.683 | -0.130 | 3 | 0.738 |
CK1G3 |
0.683 | 0.042 | -3 | 0.439 |
INSRR |
0.683 | 0.025 | 3 | 0.670 |
NEK1 |
0.682 | -0.227 | 1 | 0.635 |
PINK1_TYR |
0.682 | -0.144 | 1 | 0.645 |
FER |
0.681 | -0.002 | 1 | 0.674 |
TXK |
0.681 | 0.094 | 1 | 0.668 |
DDR1 |
0.680 | -0.050 | 4 | 0.795 |
HASPIN |
0.679 | -0.053 | -1 | 0.630 |
YANK2 |
0.679 | 0.011 | 2 | 0.352 |
FGFR2 |
0.678 | -0.034 | 3 | 0.720 |
YES1 |
0.678 | 0.006 | -1 | 0.745 |
ABL2 |
0.678 | 0.003 | -1 | 0.764 |
OSR1 |
0.678 | -0.130 | 2 | 0.520 |
BIKE |
0.677 | 0.019 | 1 | 0.650 |
SRMS |
0.677 | 0.018 | 1 | 0.657 |
LIMK2_TYR |
0.676 | -0.102 | -3 | 0.740 |
EPHB2 |
0.676 | 0.020 | -1 | 0.776 |
RET |
0.676 | -0.117 | 1 | 0.605 |
EPHB1 |
0.675 | -0.002 | 1 | 0.639 |
CSF1R |
0.675 | -0.065 | 3 | 0.672 |
KIT |
0.675 | -0.029 | 3 | 0.684 |
PTK2 |
0.674 | 0.104 | -1 | 0.732 |
MST1R |
0.674 | -0.134 | 3 | 0.692 |
CK1G2 |
0.674 | 0.050 | -3 | 0.512 |
YSK1 |
0.674 | -0.217 | 2 | 0.509 |
FGR |
0.674 | -0.031 | 1 | 0.702 |
FGFR3 |
0.674 | -0.013 | 3 | 0.704 |
FYN |
0.673 | 0.078 | -1 | 0.719 |
TYRO3 |
0.673 | -0.128 | 3 | 0.676 |
MYO3A |
0.673 | -0.119 | 1 | 0.651 |
EPHB3 |
0.672 | -0.029 | -1 | 0.771 |
ASK1 |
0.672 | -0.189 | 1 | 0.541 |
MET |
0.672 | -0.026 | 3 | 0.688 |
ROS1 |
0.672 | -0.116 | 3 | 0.656 |
TNK2 |
0.672 | -0.043 | 3 | 0.668 |
ABL1 |
0.671 | -0.034 | -1 | 0.749 |
MERTK |
0.671 | -0.030 | 3 | 0.689 |
BLK |
0.670 | 0.043 | -1 | 0.743 |
ITK |
0.670 | -0.009 | -1 | 0.728 |
KDR |
0.669 | -0.069 | 3 | 0.667 |
BMX |
0.669 | 0.022 | -1 | 0.693 |
MYO3B |
0.669 | -0.140 | 2 | 0.552 |
EPHA3 |
0.669 | -0.040 | 2 | 0.618 |
JAK3 |
0.669 | -0.106 | 1 | 0.561 |
EPHA7 |
0.669 | -0.015 | 2 | 0.621 |
PTK2B |
0.668 | 0.017 | -1 | 0.694 |
LTK |
0.668 | -0.054 | 3 | 0.662 |
DDR2 |
0.668 | 0.019 | 3 | 0.664 |
EPHA5 |
0.668 | 0.012 | 2 | 0.633 |
FLT1 |
0.668 | -0.026 | -1 | 0.806 |
LCK |
0.668 | -0.002 | -1 | 0.752 |
LIMK1_TYR |
0.668 | -0.268 | 2 | 0.608 |
TYK2 |
0.668 | -0.237 | 1 | 0.610 |
HCK |
0.667 | -0.061 | -1 | 0.741 |
FGFR1 |
0.667 | -0.115 | 3 | 0.686 |
JAK2 |
0.667 | -0.192 | 1 | 0.602 |
ALK |
0.666 | -0.073 | 3 | 0.642 |
PDGFRB |
0.666 | -0.156 | 3 | 0.690 |
ERBB2 |
0.665 | -0.083 | 1 | 0.563 |
TEK |
0.665 | -0.115 | 3 | 0.653 |
FLT3 |
0.665 | -0.124 | 3 | 0.671 |
FGFR4 |
0.665 | 0.002 | -1 | 0.751 |
PTK6 |
0.664 | -0.100 | -1 | 0.685 |
NTRK1 |
0.664 | -0.093 | -1 | 0.775 |
SYK |
0.664 | 0.067 | -1 | 0.750 |
TEC |
0.664 | -0.043 | -1 | 0.668 |
EPHA8 |
0.663 | -0.013 | -1 | 0.756 |
AXL |
0.663 | -0.119 | 3 | 0.687 |
MATK |
0.663 | -0.036 | -1 | 0.734 |
INSR |
0.662 | -0.078 | 3 | 0.638 |
SRC |
0.662 | -0.000 | -1 | 0.708 |
CSK |
0.661 | -0.039 | 2 | 0.624 |
TAO1 |
0.661 | -0.193 | 1 | 0.554 |
EGFR |
0.660 | -0.030 | 1 | 0.466 |
FLT4 |
0.660 | -0.104 | 3 | 0.660 |
IGF1R |
0.660 | -0.016 | 3 | 0.612 |
TNK1 |
0.659 | -0.123 | 3 | 0.672 |
STLK3 |
0.659 | -0.207 | 1 | 0.551 |
EPHA2 |
0.659 | 0.006 | -1 | 0.755 |
FRK |
0.659 | -0.062 | -1 | 0.769 |
LYN |
0.658 | -0.047 | 3 | 0.619 |
BTK |
0.658 | -0.141 | -1 | 0.703 |
NTRK3 |
0.658 | -0.079 | -1 | 0.744 |
ERBB4 |
0.657 | -0.004 | 1 | 0.513 |
AAK1 |
0.656 | 0.037 | 1 | 0.590 |
NEK3 |
0.656 | -0.330 | 1 | 0.581 |
WEE1_TYR |
0.656 | -0.114 | -1 | 0.719 |
NTRK2 |
0.655 | -0.155 | 3 | 0.662 |
EPHA1 |
0.655 | -0.124 | 3 | 0.663 |
PDGFRA |
0.653 | -0.241 | 3 | 0.673 |
NEK10_TYR |
0.652 | -0.174 | 1 | 0.494 |
ZAP70 |
0.649 | 0.029 | -1 | 0.684 |
JAK1 |
0.649 | -0.172 | 1 | 0.559 |
TNNI3K_TYR |
0.647 | -0.206 | 1 | 0.649 |
FES |
0.646 | -0.036 | -1 | 0.670 |
MUSK |
0.632 | -0.176 | 1 | 0.469 |